Article Information
History
- October 20, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Tomoko Nakanishi1,2,3,4,
- Yossi Farjoun2,
- Julian Willett2,5,6,
- Richard J. Allen7,
- Beatriz Guillen-Guio7,
- Sirui Zhou1,5,6 and
- J. Brent Richards1,2,8,9,10,*
- 1Department of Human Genetics, McGill University, Montréal, Québec, Canada
- 2Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
- 3Kyoto-McGill International Collaborative Program in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
- 4Research Fellow, Japan Society for the Promotion of Science, Tokyo, Japan
- 5Quantitative Life Sciences Program, McGill University, Montréal, Canada
- 6McGill Genome Centre, McGill University, Montréal, Québec, Canada
- 7Department of Health Sciences, University of Leicester, Leicester, United Kingdom
- 8Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada
- 9Department of Twin Research, King’s College London, London, United Kingdom
- 105 Prime Sciences Inc, Montréal, Québec, Canada
- ↵*Corresponding author:
J. Brent Richards, Professor of Medicine, McGill University, Senior Lecturer, King’s College London (Honorary), Pavilion H-413, Jewish General Hospital, 3755 Côte-Ste-Catherine Montréal, Québec, Canada, H3T 1E2, T: +1 514 340 8222 x24362 F: +1 514 340 7529, E: brent.richards{at}mcgill.ca www.mcgill.ca/genepi
Posted October 20, 2022.
Alternative splicing in the lung influences COVID-19 severity and respiratory diseases
